Recent studies presented at ASCO and published in the International Journal of Gynecologic Cancer, evaluated the association between prediction of response to chemotherapy and progression-free interval and overall survival in ovarian cancer.

Precision Therapeutics, Inc. today announced that CEO Sean McDonald provided a company presentation at the J.P. Morgan 28th Annual Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California, on Thursday, January 14, 2010